FIELD: heterocyclic compounds, purines, pharmacy. SUBSTANCE: invention relates to 9-β--D-arabinofuranosyl-2-amino-6-methoxy-9H-purine of the formula (I) 
and its derivatives and pharmaceutical composition that has the indicated purine derivatives. Composition shows activity against human viral infection caused by varicella/zoster virus. EFFECT: enhanced effectiveness of composition. 9 cl, 1 tbl, 58 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SYNTHESIS OF SUBSTITUTED PURINE ARABINOSIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES | 1988 |
|
RU2039752C1 |
| MONO-, DI- OR TRICOMPLEX ESTERS OF 2-AMINO-6-(C-C-ALKOXY)-9-(β-D-ARABINOFURANOSYL)-9H-PURINE, METHOD OF THEIR SYNTHESIS, USING AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2114860C1 |
| ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1992 |
|
RU2091386C1 |
| METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES | 1990 |
|
RU2068849C1 |
| METHOD OF SYNTHESIS OF 2'-DEOXY-2'-FLUORORIBONUCLEOSIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2043361C1 |
| METHOD FOR PRODUCING 2,4-DIAMINO-5-(SUBSTITUTED) PYRIMIDINES | 0 |
|
SU1306473A3 |
| METHOD OF PYRIMIDINE NUCLEOSIDE SYNTHESIS | 1989 |
|
RU2036199C1 |
| METHOD OF PRODUCING PYRIMIDINE NUCLEOSIDES | 0 |
|
SU1731064A3 |
| METHOD OF INHIBITION OF HEPATITIS B VIRAL INFECTIONS | 1992 |
|
RU2116789C1 |
| SYNERGISTIC PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT OR PROPHYLAXIS OF HIV-INFECTION | 1992 |
|
RU2110993C1 |
